Fever, pain and inflammation; endotoxaemia; adjunct in acute mastitis and respiratory disease.
Gastrointestinal ulceration; renal impairment; dehydration. Intramuscular use causes tissue damage in horses — give intravenously.
Gastrointestinal ulceration; renal damage; injection-site necrosis after intramuscular use.
Not recommended in pregnancy.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Intravenously - intramuscular use causes tissue damage and extends withdrawal. Verify against the product label before use.
Dose
1.1
mg/kg
Frequency
q12-24h
Duration
up to 5 days
Verify against the product label before use.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Verify against the product label before use.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Intravenously - intramuscular use causes tissue damage and extends withdrawal. Verify against the product label before use.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Intravenously - intramuscular use causes tissue damage and extends withdrawal. Verify against the product label before use.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Intravenously - intramuscular use causes tissue damage and extends withdrawal. Verify against the product label before use.
Dose
2.2
mg/kg
Frequency
q24h
Duration
up to 3 days
Verify against the product label before use.